ONCT

Oncternal Therapeutics, Inc. Common Stock
ONCT

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

ONCT was delisted on the 2nd of December, 2024.

Back to rankings

24 hedge funds and large institutions have $1.93M invested in Oncternal Therapeutics, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
24
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$129K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$468K
2
+$97.9K
3
+$87K
4
Morgan Stanley
Morgan Stanley
New York
+$45K
5
Goldman Sachs
Goldman Sachs
New York
+$38K

Top Sellers

1
-$282K
2
-$214K
3
-$163K
4
GCP
GSA Capital Partners
United Kingdom
-$123K
5
State Street
State Street
Massachusetts
-$104K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
–
27
–
28
–
29
–
30
–
31
–
32
–
33
–
34
–
35
–
1
2